Loading
A phase 2 trial in colorectal cancer, run by Siriraj Hospital, not yet recruiting.
A Phase II Prospective Study of Maastro Applicator Brachytherapy for Rectal Cancer is a phase 2, interventional study registered as NCT07402486 by Siriraj Hospital, with a registry enrolment figure of 20 participants, started 2026-03-01 and due to reach its primary completion in 2026-12-31. Interventions recorded: Rectal HDR brachytherapy via Maastro Applicator. Conditions listed: Rectal Cancer. Primary outcome: Clinical Complete Response (cCR) Rate. Colorectal eligibility wording from the registry: "Age ≥ 18 years at the time of informed consent Histologically confirmed rectal cancer Any T, N, or M stage, provided the primary rectal lesion is suitable for endorectal HDR brachytherapy Tumor characteristics deemed suitable for treatment with the Maastro applicator (per investigator assessment) Re". No results are recorded here; the registry entry is the source.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.